ArticleBritish journal of haematology2015

High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.

Ryan D Cassaday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.